Loading...

Horizons Marijuana Life Sciences Index ETF

HMLSF•PNK
Financial Services
Asset Management
$4.78
$0.00(0.00%)

Horizons Marijuana Life Sciences Index ETF (HMLSF) Stock Overview

Explore Horizons Marijuana Life Sciences Index ETF’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap35M
P/E RatioN/A
EPS (TTM)N/A
ROE0.00%

AI Price Forecasts

1 Week$4.68
1 Month$4.70
3 Months$4.96
1 Year Target$5.94

HMLSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Horizons Marijuana Life Sciences Index ETF (HMLSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $5.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 35M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for HMLSFStats details for HMLSF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for HMLSFAnalyst Recommendations details for HMLSF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

The fund invests in equity securities as well as ADRs of companies substantially in the same proportion as its underlying index. These securities are listed on stock exchanges in North America, and are classified as life sciences companies (including those involved in biopharmaceuticals, medical manufacturing, distribution, and bio products) as well as other companies with significant business activities in the marijuana industry. Rebalanced quarterly, the portfolio is market-cap-weighted with 10% maximum capping for each constituent.

Founded

2017

Frequently Asked Questions

;